Protagonist Therapeutics Inc. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

Protagonist Therapeutics Inc. (PTGX) — Frequently Asked Questions

Protagonist Therapeutics Inc. (PTGX) is a publicly traded US company. Explore PTGX's stock price, financial statements, earnings history, margins and key ratios below.

What is the PTGX stock price?

PTGX trades at $105.77 (-0.09% on the day).